Alpha DNA Investment Management’s Camtek CAMT Stock Holding History

Alpha DNA Investment Management’s Portfolio CAMT Stock Details CAMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,278	Closed	-$507K	–	36
2024 Q4	$507K	Buy	6,278 +1,034	+20%	+$81.3K	0.19%	100
2024 Q3	$419K	Buy	5,244 +1,310	+33%	+$128K	0.16%	163
2024 Q2	$493K	Sell	3,934 -3,227	-45%	-$308K	0.19%	110
2024 Q1	$600K	Sell	7,161 -182	-2%	-$14.3K	0.22%	105
2023 Q4	$509K	Sell	7,343 -1,864	-20%	-$113K	0.2%	121
2023 Q3	$573K	Buy	+9,207	New	+$455K	0.23%	101
2021 Q4	–	Sell	-33,057	Closed	-$1.34M	–	109
2021 Q3	$1.34M	Buy	+33,057	New	+$1.27M	0.91%	83

Other funds holding CAMT

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Alpha DNA Investment Management's CAMT Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Camtek (CAMT) in Q1 2025, closing a stake of 6,278 shares — an estimated $507K sold.

Alpha DNA Investment Management first reported a position in CAMT in Q3 2021 and held it in 7 quarters. The position peaked at $1.34M in Q3 2021. 169 funds tracked by Wall St. Rank hold CAMT as of Q1 2025.

Alpha DNA Investment Management reported no remaining Camtek position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 6,278 Camtek shares in Q1 2025, an estimated $507K.
Alpha DNA Investment Management first reported a position in Camtek in Q3 2021 and held it in 7 quarters.
Alpha DNA Investment Management's Camtek position peaked at $1.34M in Q3 2021.
169 funds tracked by Wall St. Rank held Camtek as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.